M. Piccart
- Oncology top 5%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Pathology and Forensic Medicine
- Co-authors
- P.F. BruningFátima CardosoTanja ČuferL. MauriacG. AtalayLaura BiganzoliAhmad AwadaRobert E. Coleman
- Topics
- Breast Cancer Treatment Studies (14 papers)Cancer Treatment and Pharmacology (13 papers)Advanced Breast Cancer Therapies (12 papers)
- Cited by
- Cancer ResearchOncologyDermatology
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
M. Piccart
35 papers receiving 862 citations
Peers
Comparison fields: 5 of 67
- Oncology 681
- Cancer Research 409
- Pulmonary and Respiratory Medicine 163
- Molecular Biology 154
- Pathology and Forensic Medicine 90
Countries citing papers authored by M. Piccart
This map shows the geographic impact of M. Piccart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Piccart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Piccart more than expected).
Fields of papers citing papers by M. Piccart
This network shows the impact of papers produced by M. Piccart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Piccart. The network helps show where M. Piccart may publish in the future.
Co-authorship network of co-authors of M. Piccart
This figure shows the co-authorship network connecting the top 25 collaborators of M. Piccart. A scholar is included among the top collaborators of M. Piccart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Piccart. M. Piccart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 8 | |
| 3 | 27 | |
| 4 | 2 | |
| 5 | 8 | |
| 6 | 8 | |
| 7 | 7 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 49 | |
| 11 | 67 | |
| 12 | 0 | |
| 13 | Phase II, open label study of SB-715992 (Ispinesib) in subjects with advanced or metastatic breast cancer | 9 |
| 14 | 87 | |
| 15 | 153 | |
| 16 | 59 | |
| 17 | 3 | |
| 18 | AT (doxorubicin-Taxol) versus AC (doxorubicin-cyclophosphamide) as first line chemotherapy in metastatic breast cancer (MBC): A phase III study. (originally presented at ASCO 2000. Abstract 282) | 13 |
| 19 | Combined treatment with the LHRH-agonist buserelin (LHRH-A) and tamoxifen (TAM) vs single treatment with each drug alone in premenopausal metastatic breast cancer. Final results of EORTC study 10881 | 8 |
| 20 | 86 |
About M. Piccart
M. Piccart is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 889 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (13 papers) and Advanced Breast Cancer Therapies (12 papers). The work is most often cited by research in Cancer Research (409 citations), Oncology (681 citations) and Dermatology (79 citations). M. Piccart has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include P.F. Bruning, Fátima Cardoso, Tanja Čufer, L. Mauriac, G. Atalay, Laura Biganzoli, Ahmad Awada, Robert E. Coleman, Anne Hamilton and Hervé Bonnefoi. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.